The main task of the Drug Investigation Department is to do the identification, confirmation of the illicit narcotic drugs and new psychoactive substances in seizures in order to give information to the prosecution or intelligence purposes.
In accordance with the national law, the penalty depends on the quantity of pure drugs and new psychoactive substances, therefore the laboratory has to do quantification for controlled substances including traditional and new drugs.
In specific cases the laboratory also has to compare samples collected on various sites to prove their common source. For this purpose different impurities are investigated in seized drugs, deriving either from the raw material or from the chemical process.
The analytical results of materials seized in Hungary are collected in the central database and trends are evaluated annually. This is the basis of national drug reports (see "Chapter 10 - Drug markets" in National Reports for EMCDDA).
The department plays active role in the Drugs Working Group of the ENFSI. Main activities:
- provides Proficiency Test for ENFSI laboratories (identification and quantitation of illicit drugs and new psychoactive substances)
- co-authors of ENFSI DWG Guidelines on Sampling of Illicit Drugs for Quantitative Analysis
- coordination of IR spectral library for illicit drugs and new psychoactive substances (ENFSI DWG, RESPONSE)
The laboratory is accredited since 2013 according to ISO/IEC 17025:2005 for identification of illicit drugs and quantification of main drugs. The renewal of the accreditation is in progress.
Head of the Drug Investigation Department:
Drug Investigation Department
director, forensic chemist